Temporal gene expression patterns in G93A/SOD1 mouse

References

• Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nature Revs Neurosci 2001; 2: 734–744.
   PubMed Web of Science ®Google Scholar
• Boje KM, Arora PK. Microglia-produced nitric oxide and reactive nitorgen oxides mediate neuronal cell death. Brain Res 1992; 587: 250–256.
   PubMed Web of Science ®Google Scholar
• Chapman GA, Moores K, Harrison AD, Campbell CA, Stewart BR. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 2000; 20: (RC87).
   Google Scholar
• Clement AM, Nguyen MD, Roberts EA et al. Wildtype non- neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302: 113–117.
   Google Scholar
• Dalmau I, Vela JM, Gonzalez B, Finsen B, Castellano B. Dynamics of microglia in the developing rat brain. J Comp Neurol 2003; 458: 144–157.
   PubMed Web of Science ®Google Scholar
• Eklind S, Mallard C, Leverin A et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13: 1101–1106.
   Google Scholar
• Elliott JL. Cytokine up-regulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2001; 95: 172–178.
   PubMedGoogle Scholar
• Ferrante RJ, Browne SE, Shinobu LA et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064–2074.
   Google Scholar
• Goto JJ, Zhu H, Sanchez RJ et al. Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 2000; 275: 1007–1014.
   Google Scholar
• Gurney ME. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 1997; 244: S15–S20.
   PubMed Web of Science ®Google Scholar
• Hailer NP, Wirjatijasa F, Roser N, Hischebeth GTR, Korf H-W, Dehghani F. Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N-methyl-d- aspartate-induced excitotoxic injury in organotypic hippocampal slice cultures. Eur J Neurosci 2001; 14: 315–326.
   PubMed Web of Science ®Google Scholar
• Hall ED, Oostoveen JA, Gurney MA. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23: 249–256.
   PubMed Web of Science ®Google Scholar
• Hanisch UK. Microglia as a source and target of cytokines. Glia 2002; 40: 140–155.
   PubMed Web of Science ®Google Scholar
• Hensley K, Fedynyshyn J, Ferrell S et al. Message and protein- level elevation of tumor necrosis factor a (TNFa) and TNFa- modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis 2003; 14: 74–80.
   Google Scholar
• Hensley K, Floyd RA, Gordon B et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 2002; 82: 365–374.
   Google Scholar
• Hook RM, Ruuls SR, Murphy CA et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768–1771.
   Google Scholar
• Ishigaki S, Niwa J, Ando Y et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords: screening by molecular indexing and subsequent dDNA microarray analysis. FEBS Lett 2002; 6: 354–358.
   Google Scholar
• Kawamata TH, Akiyama H, Yamada Y, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140: 691–707.
   PubMed Web of Science ®Google Scholar
• Kriz J, Gowing G, Julien J-P. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Annal Neurol 2003; 53: 429–436.
   PubMed Web of Science ®Google Scholar
• Lehnardt S, Massillon L, Follett P et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll- like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514–8519.
   Google Scholar
• Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglial activation and superoxide generation. J Pharmacol Exp Ther 2000; 293: 607–617.
   PubMed Web of Science ®Google Scholar
• Liu BJ, Jiang JW, Wilson B et al. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther 2000; 295: 125–132.
   Google Scholar
• Liu Y, Qin L, Li G et al. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degenera- tion through inhibition of microglial activation. J Pharmacol Exp Ther 2003; 305: 212–218.
   Google Scholar
• Malaspina A, Kaushik N, Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001; 77: 132–145.
   PubMed Web of Science ®Google Scholar
• Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin- 1b promotes repair of the CNS. J Neurosci 2001; 21: 7046–7052.
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26: 459–470.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Kawanokuchi J, Numata K, Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 2003; 979: 65–70.
   PubMed Web of Science ®Google Scholar
• Nguyen MD, Julien JP, Rivest SP. Innate immunity: the missing link in neuroprotection and neurodegeneration. Nat Rev Neurosci 2002; 3: 216–227.
   PubMed Web of Science ®Google Scholar
• Nishiyori A, Minami M, Ohtani Y et al. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 1998; 12: 167–172.
   Google Scholar
• Okado-Matsumoto A, Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA 2002; 99: 9010–9014.
   PubMed Web of Science ®Google Scholar
• Olsen MK, Roberds SL, Ellerbrock BR, Fleck TJ, McKinley DK, Gurney ME. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 2001; 50: 730–740.
   PubMed Web of Science ®Google Scholar
• Polazzi E, Gianni T, Contestabile A. Microglial cells protect cerebellar granule neurons from apoptosis. Glia 2001; 36: 271–280.
   PubMedGoogle Scholar
• Poloni M, Facchetti D, Mai R et al. Circulating levels of tumor necrosis factor-a and and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000; 287: 211–214.
   Google Scholar
• Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 1999; 30: 77–105.
   PubMedGoogle Scholar
• Raoul C, Estevez AG, Nishimune H et al. Motoneuron death triggered by a specific pathway downstream of fas: potentiation by ALS-linked SOD1 mutations. Neuron 2002; 35: 1067–1083.
   Google Scholar
• Rivest SP. Molecular insights on the cerebral innate immune system. Brain Behavior and Immunity 2003; 17: 13–19.
   PubMed Web of Science ®Google Scholar
• Robberecht W. Oxidative stress in amyotrophic lateral sclerosis. J Neurol 2000; 247: 1–6.
   Web of Science ®Google Scholar
• Rothstein JD, van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyo- trophic lateral sclerosis. Ann Neurol 1995; 38: 73–84.
   PubMed Web of Science ®Google Scholar
• Sayre L, Smith M, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 2001; 8: 721–738.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyo- trophic lateral sclerosis. J Neurol 2000; 247 (suppl 1): 117–127.
   Google Scholar
• Spleiss O, Appel K, Boddeke HW, Berger N. Molecular biology of microglia cytokine and chemokine receptors and microglial activation. Life Sci 1998; 62: 1707–1710.
   PubMedGoogle Scholar
• Stence N, Waite M, Dailey ME. Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 2001; 33: 256–266.
   PubMed Web of Science ®Google Scholar
• Streit W. Microglia as neuroprotective,immunocompetent cells of the CNS. Glia 2002; 40: 133–139.
   PubMed Web of Science ®Google Scholar
• Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Invest 1997; 76: 441–456.
   PubMed Web of Science ®Google Scholar
• van den Bosch L, Tilkin P, Lemmens G, Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 2002; 13: 1067–1070.
   PubMed Web of Science ®Google Scholar
• Viviani E, Corsini B, Galli CL, Marinovich M. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998; 150: 271–276.
   PubMed Web of Science ®Google Scholar
• Weydt P, Weiss MD, Moller T, Carter GT. Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis. Curr Opin Investig Drugs 2002; 3: 1720–1724.
   PubMedGoogle Scholar
• Yoshihara T, Ishigaki S, Yamamoto M et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002; 80: 158–167.
   Google Scholar
• Zhang W, Narayanan M, Friedlander RM. Additive neuroprotec- tive effects of minocycline with creatine in a mouse model of ALS. Ann Neurol 2003; 53: 267–270.
   PubMed Web of Science ®Google Scholar
• Zujovic V, Benavides J, Vige X, Carter C, Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 2000; 29: 305–315.
   PubMed Web of Science ®Google Scholar
• Chung YH, Joo KM, Lee YJ, Kim MJ, Cha CI. Immunohisto- chemical study on the aggregation of ubiquitin in the central nervous system of transgenic mice expressing a human Cu/Zn SOD mutation. Neurol Res 2003; 25: 395–400.
   PubMed Web of Science ®Google Scholar
• Niwa J, Ishigaki S, Hishikawa N et al. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxi- city. J Biol Chem 2002; 277: 36793–36798.
   Google Scholar
• Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 2001; 8: 933–941.
   PubMed Web of Science ®Google Scholar
• Brandt R. Cytoskeletal mechanisms of neuronal degeneration. Cell Tissue Res 2001; 305: 255–265.
   PubMed Web of Science ®Google Scholar
• Julien JP, Mushynski WE. Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol 1998; 61: 1–23.
   PubMed Web of Science ®Google Scholar
• Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002; 40: 133–139.
   PubMed Web of Science ®Google Scholar